Magnesium Sulfate Versus Ipratropuim Bromide in Acute Exacerbation of Chronic Obstructive Pulmonary Disease

NCT01136421 Phase 3 COMPLETED

Treatment with short acting β2 agonists for exacerbations of COPD results in clinical improvement. It has not been established whether combining short acting β2 agonists to other bronchodilators is more effective than β2 agonists alone. The aim of this study is to evaluate the efficacy and safety of combination of SABA and MgSO4 in comparison to SABA and ipratropium bromide (IB) in patients attending the emergency department for AECOPD.

Details

Lead sponsor	University of Monastir
Phase	Phase 3
Status	COMPLETED
Enrolment	124
Start date	2005-01
Completion	2007-06

Conditions

• COPD Exacerbation

Interventions

• Ipratropium bromide
• Magnesium Sulfate

Countries

Tunisia